P5 Health Ventures

Clarapath, Inc. specializes in imaging and analysis services for digital pathology, focusing on the automation of tissue processing. The company offers Section Star, an automated device that employs a tape transfer method for microtomy, enhancing the precision and efficiency of tissue sectioning. Clarapath provides a range of services, including routine histology, pathology consultation, whole slide imaging, quantitative image analysis, and long-term data management. Its anatomic pathology laboratory serves both human and animal digital pathology needs, catering to academic researchers, clinical laboratories, and physicians. The company operates from a next-generation laboratory at the NY Genome Center, facilitating large-scale imaging and analysis to support both specialized research projects and broader clinical applications. Founded in 2011 and headquartered in New York, Clarapath aims to transform anatomic pathology through its innovative approach, enabling faster and more accurate results while reducing variability and cross-contamination in tissue processing.

FIGUR8, Inc. is a Boston-based company established in 2016 that specializes in manufacturing wearable sensors designed to measure body movement as a biomarker for musculoskeletal-related conditions. The company also offers a platform that tracks and analyzes musculoskeletal health data, aiming to provide insights into human movement. Founded by a team of engineers, researchers, and designers with backgrounds in wearable computing, digital health, and sports science, FIGUR8 focuses on making advanced movement analysis accessible to a broader audience, moving beyond the elite users to everyday individuals.

Hawthorne Effect is a clinical trial data platform committed to enhancing the accessibility and convenience of clinical trials for all individuals. It achieves this through a proactive Visit Management System that strengthens the partnership between study sponsors and investigators, leveraging shared technology to ensure adherence to protocols and reduce data omissions. The platform integrates licensed healthcare professionals with advanced connected technology, facilitating decentralized clinical trials that improve efficiency and accuracy compared to traditional methods. By deploying specially trained healthcare providers, known as “HEROs,” Hawthorne Effect allows for patient visits to be conducted anywhere and at any time, thereby minimizing the risk of patients being lost to follow-up and ensuring comprehensive tracking of patient data.

Conversa Health, Inc. specializes in developing patient relationship management solutions that enhance communication between patients and healthcare providers. Its primary offering, the Conversa Virtual Care and Communication Platform, enables efficient engagement and improved health outcomes by automating personalized messaging tailored to individual patient profiles, which are derived from electronic health records, biometric devices, and self-reported data. The platform supports various healthcare scenarios, including chronic care management, acute discharge, and preventative wellness. Additionally, Conversa provides Digital Checkups that generate tailored clinical questions and reminders based on patient data. The company serves a diverse clientele, including health systems, pharmaceutical companies, payers, and health technology firms. Founded in 2013 and headquartered in Portland, Oregon, Conversa has expanded its presence with offices in New York, North Carolina, and California. Its solutions are utilized by notable organizations to manage patient engagement, especially during the COVID-19 pandemic, by facilitating symptom checks, lab result communications, and patient monitoring.

Conversa Health, Inc. specializes in developing patient relationship management solutions that enhance communication between patients and healthcare providers. Its primary offering, the Conversa Virtual Care and Communication Platform, enables efficient engagement and improved health outcomes by automating personalized messaging tailored to individual patient profiles, which are derived from electronic health records, biometric devices, and self-reported data. The platform supports various healthcare scenarios, including chronic care management, acute discharge, and preventative wellness. Additionally, Conversa provides Digital Checkups that generate tailored clinical questions and reminders based on patient data. The company serves a diverse clientele, including health systems, pharmaceutical companies, payers, and health technology firms. Founded in 2013 and headquartered in Portland, Oregon, Conversa has expanded its presence with offices in New York, North Carolina, and California. Its solutions are utilized by notable organizations to manage patient engagement, especially during the COVID-19 pandemic, by facilitating symptom checks, lab result communications, and patient monitoring.

Iterative Scopes, Inc. is a Boston-based company founded in 2017 that specializes in developing machine learning-powered diagnostic tools for gastroenterologists aimed at preventing colon cancer. The company utilizes computer vision and machine learning technologies to provide real-time computer-aided detection and diagnostic tools, which enhance the ability of doctors to detect and categorize lesions during procedures. These tools are designed to improve patient outcomes by identifying lesions that may be missed by the human eye. Additionally, Iterative Scopes offers access to deep neural networks trained by experienced gastrointestinal specialists, thereby expanding the availability of advanced diagnostic capabilities for healthcare providers globally.

FIGUR8, Inc. is a Boston-based company established in 2016 that specializes in manufacturing wearable sensors designed to measure body movement as a biomarker for musculoskeletal-related conditions. The company also offers a platform that tracks and analyzes musculoskeletal health data, aiming to provide insights into human movement. Founded by a team of engineers, researchers, and designers with backgrounds in wearable computing, digital health, and sports science, FIGUR8 focuses on making advanced movement analysis accessible to a broader audience, moving beyond the elite users to everyday individuals.

Babyscripts is a digital health platform focused on enhancing prenatal and postpartum care through a virtual approach. Designed to strengthen the relationship between patients and healthcare providers, it offers a mobile app that guides expectant mothers through their pregnancy journey with tasks related to nutrition, exercise, and other relevant behaviors. Upon enrollment by their OBGYN, patients receive a Mommy Kit, which includes internet-enabled devices such as a weight scale and blood pressure cuff. This setup allows mothers to monitor their health at home while staying connected with their healthcare providers. The app automatically captures health readings and compliance data, facilitating real-time feedback and intervention. Babyscripts collaborates with major health systems to improve care for high-risk pregnancies, continuously refining its offerings to reach more expecting mothers and address critical issues such as maternal mortality.

Cohero Health, Inc. is a digital respiratory health company that focuses on improving the management of asthma and chronic obstructive pulmonary disease (COPD). Founded in 2012 and based in New York, the company offers a proprietary connected health platform that combines sensor-based technology with a mobile application. This platform includes the BreatheSmart app, which provides customized medication reminders, records inhaler usage, and tracks lung function, symptoms, and environmental conditions over time. Cohero Health's product suite features mSpirometer lung function sensors and HeroTracker, a Bluetooth-enabled inhaler tracker that monitors both control and rescue medications. Additionally, BreatheSmart Connect serves as a Software-as-a-Service solution for remote patient monitoring and communication, enhancing coordination between patients and healthcare providers. By utilizing these tools, Cohero Health aims to improve medication adherence and overall health outcomes for individuals with respiratory conditions.